Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
INOVIO to Participate in Upcoming Scientific Conference

INOVIO to Participate in Upcoming Scientific Conference

FinvizFinviz2026/04/01 14:34
By:Finviz

PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following scientific conference:

World Federation of Hemophilia World Congress
(Kuala Lumpur)

  • Presentation
    :
    Next Gen Protein Replacement Therapeutics: DNA-Encoded Protein (DPROT) Technology Demonstrates in vivo Production of Functional FVIII in Mouse Model

    Date:
    Wednesday, April 22

    Time:
    9:45 AM MYT
  • Poster Presentation
    :
    FVIII Expression Via Non-viral Vector DNA Medicine Platform Results in Efficacious Levels of FVIII Protein and Correction of the Bleeding Phenotype in Hemophilia A Mice

    Date:
    Wednesday, April 22

    Time
    : 10:45 AM MYT

Available abstracts will be shared on INOVIO's website following presentations.

About INOVIO

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit .

Contacts

INOVIO to Participate in Upcoming Scientific Conference image 1

SOURCE INOVIO Pharmaceuticals, Inc.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

VIPKevin Warsh Sworn in as Fed Chair, Putting Broad Pressure on Crypto Assets

1. Following Kevin Warsh's appointment as Fed chair, the Fed has shifted back toward a more conservative policy stance. His hawkish position — that rates should not be cut before inflation returns to target — has significantly pushed back market expectations for easing. Holding rates steady throughout the year has now become the market's base-case scenario, while tail risks of further hikes are also beginning to be priced in. Expectations for global liquidity are tightening, although total stablecoin market capitalization in crypto continues to reach new all-time highs, with USDGO emerging as one of the fastest-growing stablecoins. 2. 10-year sovereign bond yields across major developed economies surged sharply this week: Japan climbed above 2.75% to multi-decade highs, the U.S. reached 4.57%, the UK touched 4.92%, and Germany rose to 3.14%. Yield volatility reached 3–4 sigma levels during the week, marking one of the most extreme moves since the 2022 UK pension crisis. Risk-off sentiment strengthened significantly, with capital rotating away from risk assets and into defensive assets. 3. BTC declined 1.96% this week, but the OBV volume-price divergence strategy delivered the strongest performance with +4.46% alpha. The strategy focuses on price-volume divergence signals: when price makes a new range low but OBV does not confirm with a new low, it treats this as a sign that selling momentum is fading and executes a contrarian buy on the 5-minute timeframe. Assets to watch: BTC, ONDO, HYPE, NEAR, PDD (earnings on May 27), MRVL, CRM, DELL.

Bitget2026/05/25 06:34
Kevin Warsh Sworn in as Fed Chair, Putting Broad Pressure on Crypto Assets